GB9513508D0 - Quinazoline derivatives - Google Patents

Quinazoline derivatives

Info

Publication number: GB9513508D0
Authority: GB; United Kingdom
Prior art keywords: quinazoline derivatives; quinazoline; derivatives
Prior art date: 1995-07-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GBGB9513508.3A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Fujisawa Pharmaceutical Co Ltd

Original Assignee

Fujisawa Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-03

Filing date

1995-07-03

Publication date

1995-09-06

1995-07-03 Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd

1995-07-03 Priority to GBGB9513508.3A priority Critical patent/GB9513508D0/en

1995-09-06 Publication of GB9513508D0 publication Critical patent/GB9513508D0/en

1996-07-01 Priority to JP9504991A priority patent/JPH11508588A/en

1996-07-01 Priority to PCT/JP1996/001825 priority patent/WO1997002254A1/en

1996-07-01 Priority to AU62437/96A priority patent/AU6243796A/en

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

GBGB9513508.3A 1995-07-03 1995-07-03 Quinazoline derivatives Pending GB9513508D0 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GBGB9513508.3A GB9513508D0 (en)	1995-07-03	1995-07-03	Quinazoline derivatives
JP9504991A JPH11508588A (en)	1995-07-03	1996-07-01	Quinazoline derivatives
PCT/JP1996/001825 WO1997002254A1 (en)	1995-07-03	1996-07-01	Quinazoline derivatives
AU62437/96A AU6243796A (en)	1995-07-03	1996-07-01	Quinazoline derivatives

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9513508.3A GB9513508D0 (en)	1995-07-03	1995-07-03	Quinazoline derivatives

Publications (1)

Publication Number	Publication Date
GB9513508D0 true GB9513508D0 (en)	1995-09-06

Family

ID=10777048

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9513508.3A Pending GB9513508D0 (en)	1995-07-03	1995-07-03	Quinazoline derivatives

Country Status (4)

Country	Link
JP (1)	JPH11508588A (en)
AU (1)	AU6243796A (en)
GB (1)	GB9513508D0 (en)
WO (1)	WO1997002254A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0896961A4 (en) *	1995-12-28	1999-04-07	Fuji Chem Ind Co Ltd	Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
WO1999012930A1 (en)	1997-09-05	1999-03-18	Glaxo Group Limited	2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
DE10056312A1 (en)	2000-11-14	2002-05-16	Bayer Ag	New 1-(N-substituted amidoalkyl) bicyclic uracil derivatives useful as medicaments for treating ischemia or reperfusion damage, are poly-(ADP-ribose)-synthetase inhibitors
US10016425B2 (en)	2016-11-03	2018-07-10	King Saud University	Anti-ulcerative colitis compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3172006D1 (en) *	1980-05-22	1985-10-03	Masayuki Ishikawa	Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof

1995
- 1995-07-03 GB GBGB9513508.3A patent/GB9513508D0/en active Pending
1996
- 1996-07-01 WO PCT/JP1996/001825 patent/WO1997002254A1/en active Application Filing
- 1996-07-01 JP JP9504991A patent/JPH11508588A/en active Pending
- 1996-07-01 AU AU62437/96A patent/AU6243796A/en not_active Abandoned

Also Published As

Publication number	Publication date
AU6243796A (en)	1997-02-05
WO1997002254A1 (en)	1997-01-23
JPH11508588A (en)	1999-07-27

Publication	Publication Date	Title
EG24134A (en)	2008-08-06	Quinazoline derivatives
HRP960147B1 (en)	2002-04-30	Quinazoline derivatives
GB9508537D0 (en)	1995-06-14	Quinazoline derivatives
GB9508535D0 (en)	1995-06-14	Quinazoline derivative
ZA951458B (en)	1996-08-22	Quinazoline derivatives
AU5343096A (en)	1996-11-18	Quinazoline derivatives
GB9607729D0 (en)	1996-06-19	Quinazoline derivatives
HU9700344D0 (en)	1997-03-28	Substituted quinazoline derivatives
ZA9610725B (en)	1997-06-26	Tyrosine derivatives
GB2306473A8 (en)	1997-05-28	Glucoxide derivatives
GR3035577T3 (en)	2001-06-29	Benzisothiazolyl-substituted aminomethylchroman derivatives
GR3036572T3 (en)	2001-12-31	4-amino-benzoylguanidine derivatives
EP0754668A3 (en)	1997-08-27	Fluorobenzylether derivatives
GB9516349D0 (en)	1995-10-11	Aza-anthracyclinone derivatives
GB9513508D0 (en)	1995-09-06	Quinazoline derivatives
GR3036344T3 (en)	2001-11-30	4-mercapto-benzoylguanidine derivatives
EP0804205A4 (en)	1998-05-20	4-aza-19-norandrostane derivatives
GB9708363D0 (en)	1997-06-18	Imidazopyridedine derivatives
GB9508567D0 (en)	1995-06-14	Quinazoline derivative
GB9508566D0 (en)	1995-06-14	Quinazoline derivative
GB9508536D0 (en)	1995-06-14	Quinazoline derivative
GB9508568D0 (en)	1995-06-14	Quinazoline derivative
GB9603049D0 (en)	1996-04-10	Quinazoline derivatives
GB9700695D0 (en)	1997-03-05	Quinazoline derivatives
GB9606865D0 (en)	1996-06-05	Quinazoline derivatives